官方服务：
资源简介：
Subset of Data from Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis (10.1016/j.cell.2015.05.047).
应用场景：
创建时间：
2022-05-25
相关数据集
Chronic IL-15 stimulation and impaired mTOR signaling and metabolism in natural killer cells during acute myeloid leukemia. Chronic IL-15 stimulation and impaired mTOR signaling and metabolism in natural killer cells during acute myeloid leukemia
We report the application of single-molecule-based sequencing technology for high-throughput profiling of histone modifications in mammalian cells. By obtaining over four billion bases of sequence fro
NIAID Data Ecosystem50
Table 5_Identification of hub genes and immune-related pathways in acute myeloid leukemia: insights from bioinformatics and experimental validation.xlsx
BackgroundThis study aims to identify the hub genes and immune-related pathways in acute myeloid leukemia (AML) to provide new theories for immunotherapy. MethodsWe use bioinformatics methods to find
NIAID Data Ecosystem10
Table 8_Identification of hub genes and immune-related pathways in acute myeloid leukemia: insights from bioinformatics and experimental validation.docx
BackgroundThis study aims to identify the hub genes and immune-related pathways in acute myeloid leukemia (AML) to provide new theories for immunotherapy. MethodsWe use bioinformatics methods to find
NIAID Data Ecosystem00
Data_Sheet_1_PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia.docx
Intratumoral accumulation of CD4+CD25+Foxp3+ regulatory T (Treg) cells occurs in acute myeloid leukemia (AML), but little is known about the role of tumor cells themselves in this process. Here, we sh
NIAID Data Ecosystem30
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses [RNA-Seq]. Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses [RNA-Seq]
There is increasing recognition of the prognostic significance of tumor cell major histocompatibility complex (MHC) class II expression in anti-cancer immunity. Relapse of acute myeloid leukemia (AML)
NIAID Data Ecosystem10
